The Research and Development Team at Pliant Therapeutics is dedicated to advancing the company's drug development programs targeting fibrotic diseases. This team engages in the discovery, design, and optimization of novel therapies with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway. Members collaborate closely to conduct experimental research, develop clinical candidates, and transition promising compounds from preclinical studies to clinical trials.
Bertus Eksteen
Scientific Advisor
Bill DeGrado
Scientific Advisor
Bill Greenlee
Scientific Advisor
Brian Metcalf
Scientific Advisor
Eve-Irene Lepist
VP, Non-Clinical Development
Fernando Rock
VP, Drug Discovery
Hal Chapman
Scientific Advisor
Naftali Kaminski
Scientific Advisor
Rik Derynck
Scientific Advisor
Shuguang Zhu
SVP, Chemistry, Manufacturing ...
View all